Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroprotective Effect of Memantine and Rosuvastatin Against Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer

NCT07504198 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT07504198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07504198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroprotective Effect of Memantine and Rosuvastatin Against Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer
Lead sponsor
Tanta University
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
March 31, 2026
Completion date
May 31, 2027
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral nerve disease